AMNEAL PHARMACEUTICALS, INC. (AMRX) Free cash flow 2016–2025
AMNEAL PHARMACEUTICALS, INC. (AMRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$269.9MFY2025 · since FY2016: -$7.7M → $269.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $269.9M | +11.0% |
| FY2024 | $243.2M | -19.6% |
| FY2023 | $302.4M | +1517.5% |
| FY2022 | $18.7M | -90.4% |
| FY2021 | $194.1M | -39.8% |
| FY2020 | $322.6M | +809.3% |
| FY2019 | -$45.5M | -127.2% |
| FY2018 | $167.1M | +19.9% |
| FY2017 | $139.4M | +1911.5% |
| FY2016 | -$7.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice